Clinical Trials

91 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06013683 2023-10-10

A Registry for Patients With Systemic Mastocytosis in China

150 enrolled

Mastocytosis, Systemic

NCT04888741 2023-09-28

MoTD

LymphoidMyeloidOther hematologic neoplasmPlasma cell

400 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT01004640 2023-09-14

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

60 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05993052 2023-08-15

Carotid Plaque Burden in Patients With Philadelphia Negative Myeloproliferative Neoplasms

100 enrolled

Myeloproliferative Disorders

NCT05993065 2023-08-15

Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in Polycythemia Vera and Secondary Erythrocytosis.

100 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Polycythemia Vera

NCT05005299 2023-08-01

VICTORY

Phase 1 Unknown

18 enrolled

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05782985 2023-07-25

Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

52 enrolled

Myeloproliferative Disorders

NCT05923372 2023-07-12

DALY-MAST

160 enrolled

Mastocytosis, Mastocytosis, Systemic

NCT00662090 2023-05-24

EWOG MDS 2006

260 enrolled

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Juvenile

NCT05140811 2023-05-24

A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Phase 1/2 Unknown

126 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05821738 2023-05-09

Avapritinib in CBF-AML With KIT Mutations

50 enrolled

Core Binding Factor Acute Myeloid Leukemia

NCT05823714 2023-04-21

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

70 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05714592 2023-02-22

MYELOCARTOCH

300 enrolled

Myeloproliferative Disorders

NCT05600959 2022-11-01

Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH

60 enrolled

LymphoidMyeloid

Disease, Lymphoma, Lymphohistiocytosis, Hemophagocytic

NCT04226768 2022-10-04

Enhanced Palliative Care in MDS and AML

90 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05566535 2022-10-04

QoL-PV-R

32 enrolled

Polycythemia Vera

NCT04155411 2022-07-27

Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP

Phase 4 Unknown

65 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05401864 2022-06-08

Characteristics of Patients With Philadelphia Negative Myeloproliferative Neoplasms at Assiut University Hospital

50 enrolled

Philadelphia Negative Myeloproliferative Neoplasms

NCT05154474 2022-05-03

SPACE2

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

150 enrolled

Anemia, Refractory, with Excess of Blasts, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Sarcopenia

NCT04764513 2022-03-28

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Phase 1/2 Unknown

20 enrolled

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05001386 2022-03-17

ESAAC

LymphoidMyeloidOther hematologic neoplasmPlasma cell

800 enrolled

Hypersensitivity, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Hematologic Neoplasms

NCT05282719 2022-03-16

Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults

33 enrolled

Myelodysplastic-Myeloproliferative Diseases

NCT02602314 2022-01-20

SUSTRENIM

Phase 4 Unknown

450 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01752062 2022-01-05

CML1012

148 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01761890 2022-01-05

CML1113

147 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05175508 2022-01-03

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Phase 2/3 Unknown

180 enrolled

Frailty, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT05092048 2021-10-25

Case-Only

10,000 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05084872 2021-10-20

HCQMa

Phase 2/3 Unknown

30 enrolled

Mastocytosis

NCT05080829 2021-10-18

Myeloid Mutations Register in R/R CML

29 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05066958 2021-10-04

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Phase 1/2 Unknown

20 enrolled

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Virus Diseases, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04631458 2021-09-16

Mascot

40 enrolled

Myeloproliferative Disorders, Thrombosis

NCT05008666 2021-08-17

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

37 enrolled

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04999878 2021-08-11

RUE-DDGP

Phase 4 Unknown

30 enrolled

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04991532 2021-08-05

Dasatinib Down-regulates the Expression of PD-1 and Enhances Killing pH + Leukemia Stem Cells

324 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04370457 2021-08-04

MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies

300 enrolled

Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04906031 2021-06-09

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

5 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

102 enrolled 12 charts

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

NCT02530619 2021-05-26

Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia

26 enrolled 10 charts

Leukemia, Megakaryoblastic, Acute, Primary Myelofibrosis

NCT02124174 2021-04-26

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Classical hematologyMyeloidOther hematologic neoplasm

50 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04818619 2021-03-29

TIGIT in Patients With Chronic Myeloid Leukemia

65 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03800095 2021-03-24

CALVI

Phase 3 Unknown

140 enrolled